How does Metoclopramide affect gastrointestinal motility in patients with scleroderma and what are the observed benefits or limitations of its use?
Lakshya KumarExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Metoclopramide enhances GI motility in scleroderma by increasing LES tone and promoting gastric emptying. Benefits include reduced GERD symptoms; limitations involve potential side effects like drowsiness or anxiety.